
Opinion|Videos|December 5, 2024
Early Recognition and Use of Biologics to Manage Hidradenitis Suppurativa
Author(s)Jennifer Hsiao, MD, Rani Cooper, MD
Panelists discuss how early recognition of hidradenitis suppurativa coupled with timely initiation of biologic therapies can significantly improve treatment outcomes and prevent disease progression.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline
2
10 Skin Cancer Exam Tips
3
Uncovering the Autoimmune Links & Systemic Impact of Chronic Spontaneous Urticaria
4
The Evolving CSU Pipeline: Biologics, BTK Inhibitors, and Biomarker-Guided Care
5






